Purchase Order 36C25719P0250
- Not listed
- This is a firm fixed-price delivery order awarded to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 10. The $84,255.34 contract is for the company's Decipher Prostate Cancer Testing services, which provide genomic analysis to help clinicians make more informed treatment decisions for prostate cancer patients. Veracyte is a for-profit organization that specializes in advanced molecular...
- This is a federal contract award to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., for DECIPHER PROSTATE CANCER TESTING services. The contract, valued at $3,240.59, was awarded by the Veterans Integrated Service Network 17 (VISN 17) of the Department of Veterans Affairs (VA). This is a Firm Fixed Price Blanket Purchase Agreement (BPA) Call contract under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract does...
- This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc. The contract, valued at $194,435.40, is a Blanket Purchase Agreement (BPA) call order issued under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) contract vehicle. The contract is for Veracyte Labs to provide its proprietary Decipher Prostate Cancer Test, a genomic classifier that...
- This firm fixed price delivery order was awarded by the Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, operating through its Decipher Biosciences, Inc. division. The $9,722 contract calls for the provision of Veracyte's proprietary Decipher Molecular Prostate Oncology Assay, which utilizes genomic testing to analyze tumor gene expression patterns and aid in personalized treatment planning for prostate cancer patients. The award was made under Veracyte's existing Federal...
- This is a firm fixed price contract awarded by the Veterans Health Administration's Veterans Integrated Service Network 8 (VISN 8) to Veracyte Labs SD Corporation, a division of Veracyte, Inc. The contract, valued at $372,667.85, is for the delivery of the Decipher Prostate Cancer Test, a specialized genomic diagnostic service that analyzes tumor gene expression patterns to help clinicians assess prostate cancer risk and guide treatment decisions. The contract is a Blanket Purchase Agreement...
- This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 21 (VISN 21) of the U.S. Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc. The contract is for the provision of Veracyte's proprietary Decipher Prostate Cancer Testing, Packaging, and Transport services to the VA San Francisco healthcare facility. The contract has a ceiling value of $648,118.00 and a period of performance through...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Veracyte, Inc., for the modification of the Decipher Prostate Cancer Testing service. The $64,811.80 contract has an ultimate completion date of November 14, 2026 and is not set aside. Veracyte, a for-profit medical diagnostics company, provides specialized genomic testing services to support precision medicine and personalized...
- This federal contract award, valued at $61,571.21, was issued by the Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc. The contract is a Blanket Purchase Agreement (BPA) call under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract is for the Decipher Prostate Cancer Testing service, which analyzes tumor gene expression patterns to help clinicians make more informed treatment...
- This delivery order, awarded to Veracyte Labs SD Corporation (a division of Decipher Biosciences, Inc.) on April 15, 2023, represents Option Year 2 of a contract to provide Decipher Prostate Testing services to Veterans Integrated Service Network 10 (VISN 10). The contract, valued at $408,314.34 on a firm fixed-price basis, will be performed in Ann Arbor, Michigan, with an ultimate completion date of November 14, 2025. This award was not subject to any small business set-aside and is established...
- The U.S. Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) call contract to Veracyte Labs SD Corporation, operating through its Decipher Biosciences, Inc. division, for $294,893.69 to provide the Decipher Prostate Cancer Test. This specialized genomic test analyzes tumor gene expression patterns to help clinicians make more informed treatment decisions for prostate cancer patients, supporting the VA's efforts to deliver precision medicine for veterans. The contract...
This is a $138,785.00 firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc. The contract is for decipher testing services to support the North Texas VA Health Care System. Veracyte Labs SD Corporation provides genomic and molecular diagnostic testing services, including the proprietary Decipher Prostate Cancer Test, to aid clinical decision making and personalized treatment of prostate cancer patients. This contract is not associated with any set-aside designation. Veracyte Labs SD Corporation holds multiple federal contract vehicles, including a Federal Supply Schedule (FSS) contract, to provide these specialized cancer diagnostic services to the VA's personalized medicine initiatives for veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Supplemental Agreement for work within scope | ($471k) | 1/28/21 | |
| P00001 | Exercise an Option | $203.1k | 3/30/20 | |
| Not listed | Not listed | $406.2k | 2/28/19 |